The authors perform a scoping review to summarize literature on the impact of HAART on HPV infection and cervical disease, for the purpose of identifying research gaps. Given the increase in access to HAART, and its seemingly complex association with HPV/cervical carcinogenesis, this study is timely. Research gaps need to be identified and addressed in order to inform cervical cancer screening guidelines in HIV-infected women.
1. The authors perform a scoping review, but do not define this approach in much detail. The objectives and presentation of results might have greater clarity if readers had more background on scoping reviews, including how these are distinct from systematic reviews. It would also be beneficial to mention why a scoping review is the preferred approach for the stated research question. It is somewhat confusing when the authors include "to systematically review" among their objectives, both in the Abstract (p.2, line 16) and the Introduction (p.4, line 49). 2. The study selection and data extraction processes are clearly defined. 3. The headings in the Results section are helpful in summarizing and grouping studies. However, the Results read as a mere summary of the literature. It would be helpful to apply more meaning to results. Levac and colleagues (Implementation Science 2010) discuss incorporating a numeric summary and qualitative thematic analysis. Something along these lines would be helpful in summarizing the literature. 4. For the Results "Summary of studies on frequency of SIL and carcinoma and risk factors for women on HAART", how was SIL status determined solely by Pap testing in each of the studies? Were results always stratified by LSIL/HSIL? CIN is also mentioned; was this histologically confirmed? Also, the organization of study summaries jumps from risk of SIL to risk factors back to risk of lesions, making it even harder for readers to draw conclusions or synthesize findings from individual studies. Topic sentences/paragraph transitions would help tie similar studies together and identify why other studies are different. 5. In the section on "Summary of studies on the impact of duration of HAART intake on the regression/progression of cervical lesions or HPV incidence," which studies failed to show the duration of HAART to be a significant predictor? These don't appear to be mentioned in any detail. 6. The Table is critical in synthesizing information from the studies for readers. However, it is not concise or easy to read. Is there a way that qualitative themes can be highlighted? Can studies on similar exposures/outcomes be grouped together in a meaningful way? Furthermore, similar terminology and format should be used throughout. For instance, in the column on study design/sample size, sometimes the term "cross sectional study" is used; sometimes "cross sectional design"; then "hospital-based cross-sectional study" makes it difficult for readers scanning the table to visually group this with other cross-sectional studies. Additionally, for the column on exposure and outcome of interest, the authors could clearly state "Exposure: …" and "Outcome:…" for each study. In the column on main results/remarks, the measure of effect is not always stated, nor are abbreviations defined in footnotes. The Table would be much more reader-friendly if studies were entered as consistently and concisely as possible. 7. In the Conclusion, the authors make the important point that screening protocols are difficult to establish in the absence of a greater body of prospective data.
Minor comments: 1. The paper could benefit from editing for style and grammar. 2. p.3 line 19: The authors refer to "low middle income countries" where I believe they intend to refer to "low and middle income countries" or "less developed countries". 3. P.3 line 38: The authors refer to "HIV 1 and HPV 2" -I believe this should be "HIV-1 and HIV-2". 4. P. 7, line 38: The authors state that one study could be explored to address two sub-questions in the review. It may not be necessary to state this, and it is confusing what "sub-questions" are referred to. 5. P. 12, line 12: A reference appears to be missing. 6. P. 11, line 42: how is baseline CD4+ count defined in the studies? 7. P. 12, line 55: What is meant by the "reservoir"? 8. 
GENERAL COMMENTS
In this present manuscript Menon et al performed a literature review to document current existing evidences on the association between the use of antiretroviral therapy (ART) and the presence of cervical premalignant and malignant conditions among HIV-infected women in sub-Saharan Africa. This review is timely and contributes to the growing literature exploring the potential impact of ART on the occurrence of cervical precancerous lesions and cervical cancer among HIV-infected women in Sub-Saharan Africa.
However, there are several limitations that need to be addressed:
Major comment 1: There is limited explanation on the natural history of HPV acquisition and how it can lead to an invasive cancer in this review. This should be more developed in the introduction (or the discussion section) and the presented outcomes (HR-HPV, SILs, CIN 1/2/3, ICC) more clearly defined. This remark leads to a suggestion in the results presentation: I would present the selected reports according to the studied outcomes: 1) HAART and HR-HPV, 2) HAART and precancerous lesions (SILs, CIN), 3) HAART and ICC. Within these three paragraph I would present study design (prevalence, incidence, regression…) and potential confounding factors including CD4 count measures.
Major comment 2: Authors listed three different objectives that are confusing to me. First they proposed to "address the prevalence/incidence of HPV, precancerous dysplasia and invasive cervical cancer in Women on HAART". I see no clear results (and discussion) providing those kind of estimates (this is not the aim of this review). The second objective should be the only one and should review the exiting evidences on the association between the use of HAART and premalignant/malignant cervical lesions (authors should remove the term impact cf. major comment 7) in subSaharan Africa. The third one is not clear: it should be part of the second as immune status is mediated by HAART exposure (CD4 count measure considered as a confusing factor). Or maybe authors would like to extend their review to the role of immunodeficiency on premalignant/malignant cervical lesions in sub-Saharan Africa. In this case, why restricting this confounding factor to a baseline measure: authors take should into account all past history of CD4 count measures.
Major comment 3: There are limited references to studies conducted on the impact of HAART and immune status on premalignant/malignant cervical lesions from high-income countries. It would be relevant to confront results reported from sub-Saharan Africa to what has been previously published in high income countries and discuss these aspects in the discussion section.
Major comment 4: page 15, line 4 to 8: the sentence is not appropriate: you cannot say that the incidence of ICC is expected to decrease thanks to the less competing mortality. As women are accessing HAART, their life expectancy will increase (age is the main risk factor for cancer) and their chance of dying from a competitive cause (opportunistic infection) will fall; These two elements will increase the chances for a premalignant condition to transform into an invasive cervical cancer. Inversely, a prolonged use of HAART might potentially prevent the acquisition of HR-HPV and/or evolution to invasive cervical cancer. A crucial point was also not raised in the manuscript: it takes several years to decades for low grade lesions to transform into an invasive cancer. This aspect implies that measuring a potential role of HAART on the occurrence of ICC would need long term follow-up to detect any impact. This aspect should be raised in the discussion section. 
Minor comments
The term "cervical disease" in the abstract section is not appropriate as it refers to malignant as well as non-malignant cervical conditions. Authors should be more specific in their wording.
Highly Active Anti-Retroviral Therapy (HAART) is defined first in the abstract section (page 2, line 11) but not in the main text: introduction (page 4, line 3). Moreover, authors used a variety of abbreviations for the same term: page 10 line 27: "ART", page 10, line 42: "c-ART". Authors should ensure that abbreviations should be harmonized throughout the manuscript.
In the method section: (page 5, line 35), only HIV-infected women with a documented HAART status were included. However, it is not clear if these women needed to have an HPV status and/or? a histological assessment. In addition, the presence of squamous intraepithelial lesions defined with cytological examination is not cited here. Page 5, line 44: did you mean that only reports including risk factors for CIN2+ were included? In this case, many of your selected articles should not be part of your selection. Page 6, line 4: again, your criteria are not clear: did you mean that only women with a documented status could be included in your final selection?
Results in the abstract (page 2, line 26): this is quite a lapidary sentence. This part needs to be rewrite: the aim of the result part is to present the findings of your review: the objective of your review was not to count the number eligible publications. You should summarize in this section the overall results of your objective(s).
Page 3, line 38: authors should delete HPV 2: did you mean HIV-2? Please provide precisions.
Page 3, line 53 throughout page 4, line 6: You should use quantitative assessment of the impact of HAART on the incidence of Kaposi sarcoma as well as Lymphomas with caution. Indeed, you are citing quite old references. The drop in the incidence of KS is far more important than two third.
Page 7, line 45: Study design & Geographic distribution: A figure presenting the distribution of studies as well as their study design on a map of sub-Saharan Africa would be great (discretionary revision).
Page 9, line 58: Authors are referring to a report without any reference to a publication (Bogaert et al, 2013) . Please add this reference to the list.
Page 21 and 23: duplicated flow charts Flow chart: "7 references excluded as none relevant": please provide details
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 -Nicole Campos Dear Nicole Campos, Thank you very much for your professional, encouraging and relevant comments. We are very grateful that you consider our study timely for the public health agenda. We highly appreciated your comments and suggestions aiming at improving our manuscript. Please, remain reassured that we did our best to address each comment, being major or minor, and to amend our manuscript accordingly. Please, find below our answers to your comments. Major comment 1: your comment invited us to revisit our research question as well as the methodology required to answer it. Indeed, we had actually performed a "systematic review" (rather than a "scoping review"), hence the ill-defined methodology in the first version. We therefore reflected this both in the title and methods. Major comment 2: thank you for your positive comment. We tried to improve this part to be more consistent with a systematic review. Major comment 3: we tried to give more meaning to the results section and not limiting the section to a mere description; however, our interpretation of the results remains more developed in the discussion section, hoping that this is acceptable for you. We also included a qualitative analysis of the retrieved studies and summarized this in a table.
Major comment 4: the other reviewer also gave a similar comment to yours. We tried to clarify how diagnosis were done for the retrieved studies. Moreover, we reorganized the results section to make it clearer (also following the other reviewer suggestion). In fact, we have reorganized it in three main sub-headings concerning the association of HAART on HPV infection, on pre-cancerous lesions and on cervical cancer. We hope that this change will make this part stronger and easier to follow. Major comment 5: we hope that, in the attempt to improve our results section (as per your comment 4), we also made clear which studies have or have not shown an association with the outcome of interest. Major comment 6: we tried our best to improve the table with the summary of the studies, mostly concerning exposures and outcomes. To improve clarity, we split the table into two; one for the association with HPV infection and one for the association with precancerous and cancerous lesions. We also tried to harmonize the terminology used, but at the same time, we tried to remain faithful to how the authors of each study defined their study. Major comment 7: thank you for your positive comments on our conclusions. We have even tried to improve our conclusions on the basis on additional studies that were included. Minor comments: we amended, corrected and clarified the manuscript according to the 8 minor comments you raised.
Reviewer 2 -Antoine Jaquet Dear Antoine Jaquet, Thank you very much for your professional and relevant comments. We are very grateful that you consider our study timely for the public health agenda and that you recognize a potential of our paper in contributing to the literature on the effect of HAART in HIV-infected women. We highly appreciated your comments and suggestions aiming at improving our manuscript. Please, remain reassured that we did our best to address each comment, being major or minor, and to amend our manuscript accordingly. Please, find below our answers to your comments. Major comment 1: we added a short paragraph on the HPV acquisition and we also re-organized the results section exactly following your suggestion (HAART and HPV; HAART and precancerous lesions; HAART and ICC). By re-reading the manuscript after this re-organization, we can only recognize that the flow and understandability of the paper has improved. Thank you for your suggestion. Major comment 2: your comment invited us to reflect and reframe our research question and the objective(s) of our review. We realized that your suggestion to keep one focused objective of the review ("review the evidence of association between HAART premalignant and malignant cervical lesions") is very relevant and therefore we amended accordingly. Major comment 3: we included a comparison with results from high-income countries (we retrieved a relevant meta-analysis) in the discussion section. We realize that this point brings an interesting perspective.
Major comment 4: we are sorry if we made this part confusing. Your comment made us realize that we had inadequately expressed the link between life expectancy, access to HAART and probability of onset of cervical lesions. We reviewed and corrected this part this part following your recommendation. Major comment 5: we removed the part on drug resistance; we realized that this part, a part from being a bit out-of-date, dilutes the focus of the paper. Major comment 6: We cited the literature and kept this paragraph as we believe it may be a factor to consider within the sub Saharan African context Major comment 7: following your remark and the fact that most retrieved studies are cross-sectional, we revised the title to better reflect the "epidemiological association" as opposed to "impact", which, as you highlight, is not appropriate given the nature of our results. Therefore, the title of our manuscript, as well as other relevant parts of the paper, have been amended to reflect this. We also included the study you suggested, although it was published after we firstly submitted our paper, since we considered it very relevant for our review. Minor comments: we amended, corrected and clarified the manuscript according to the various minor comments you raised. 
VERSION 2 -REVIEW REVIEWER

VERSION 2 -AUTHOR RESPONSE
Answers to reviewer(s) -Antoine Jaquet Dear Antoine Jaquet, Thank you very much for your time to review, once again, our manuscript. Your relevant comments help fine-tune and improve the manuscript. Please, remain reassured that we did our best to address each comment and to amend our manuscript accordingly. Please, find below our answers to your comments. Comment 1: we corrected the term "cervical invasive neoplasia" into "cervical intraepithelial neoplasia" Comment 2: we harmonized the term and we used HPV infection/prevalence Comment 3: we realized our error here; as you rightly point out, we stated that the use of HAART "decrease" the prevalence of HR-HPV, so the terms "positive association" is not correct (it should rather be the opposite). We changed this as "significant and inverted association". Comment 4: we realized that there was a reference missing; there must have been a problem with the Word formatting. We make sure to correct this. Comment 5: we reviewed the studies in table 3 and actually the two studies you mentioned report numbers of HIV+ and HIV-participants. We, however, mentioned in the limitation that, for some studies, there may be some doubt about the accuracy of the HIV results. In addition with slightly corrected the table to avoid any confusion on the number of participants who are either HIV positive or negative. Comment 6: we added the quantitative values/results in the table concerning this study (percentages and p-values) although this study does not report ratio measures. This study is one of the few that did not find an association between HAART and cervical disease. In order not to be blamed of "publication bias", if it is acceptable for you, we would like to keep this study in the review to show that the results are not always consistent across studies and some studies may find no association.
